PMID- 10583595 OWN - NLM STAT- MEDLINE DCOM- 20000104 LR - 20191210 IS - 0019-2805 (Print) IS - 1365-2567 (Electronic) IS - 0019-2805 (Linking) VI - 98 IP - 3 DP - 1999 Nov TI - Nitric oxide and macrophage antiviral extrinsic activity. PG - 363-70 AB - In this study we evaluated the relationship between nitric oxide (NO) and macrophage antiviral extrinsic activity. Macrophages activated by intraperitoneal injection of herpes simplex virus-2 (HSV-2), showed both extrinsic antiviral activity and high nitrite production in contrast to non-activated, resident macrophages. The extrinsic antiviral activity was observed in cultures of Vero cells infected with HSV-1 and HSV-2. The NO inhibitor N-monomethyl-l-arginine acetate (l-NMA) impaired the antiviral activity of HSV-elicited macrophages. The effect was dose dependent and correlated with a reduction of nitrite in the culture media. The effect of l-NMA was reversed by the addition of l-arginine. These data indicate that NO could be responsible for the described activity. Furthermore, l-NMA treatment resulted in the aggravation of HSV-1-induced keratitis in the mouse model, supporting a defensive role of NO in the pathogenesis of HSV-1 corneal infection. FAU - Benencia, F AU - Benencia F AD - Department of Biological Chemistry, Faculty of Sciences, University of Buenos Aires, Ciudad Universitaria, Argentina. FAU - Courreges, M C AU - Courreges MC LA - eng PT - Journal Article PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Nitrites) RN - 27JT06E6GR (omega-N-Methylarginine) RN - 31C4KY9ESH (Nitric Oxide) SB - IM MH - Animals MH - Chlorocebus aethiops MH - Dose-Response Relationship, Drug MH - Female MH - Herpesvirus 1, Human MH - Herpesvirus 2, Human/*immunology MH - Keratitis, Herpetic/*immunology/metabolism MH - *Macrophage Activation MH - Macrophages, Peritoneal/drug effects/*physiology MH - Mice MH - Mice, Inbred BALB C MH - Nitric Oxide/antagonists & inhibitors/*metabolism MH - Nitrites/metabolism MH - Vero Cells MH - Virus Replication/*immunology MH - omega-N-Methylarginine/pharmacology PMC - PMC2326934 EDAT- 1999/12/03 00:00 MHDA- 1999/12/03 00:01 PMCR- 2000/11/01 CRDT- 1999/12/03 00:00 PHST- 1999/12/03 00:00 [pubmed] PHST- 1999/12/03 00:01 [medline] PHST- 1999/12/03 00:00 [entrez] PHST- 2000/11/01 00:00 [pmc-release] AID - imm864 [pii] AID - 10.1046/j.1365-2567.1999.00864.x [doi] PST - ppublish SO - Immunology. 1999 Nov;98(3):363-70. doi: 10.1046/j.1365-2567.1999.00864.x.